Clinical trials
Recruiting Phase 1/2 Rectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| A2 Biotherapeutics Inc. | 2 |
| Blueprint Medicines Corporation | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| Essen Biotech | 1 |
| Fudan University | 1 |
| GlaxoSmithKline | 1 |
| ModeX Therapeutics, An OPKO Health Company | 1 |
| National Cancer Institute (NCI) | 1 |
| QuantumLeap Healthcare Collaborative | 1 |
| Revolution Medicines, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 14 |
| Colonic Neoplasms | 10 |
| Colorectal Neoplasms | 7 |
| Pancreatic Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.